|
Milacron Expands Line of
Electric Injection Molding Machines
Milacron announced this week an addition to its
line of electric Fanuc Roboshot injection molding machines in the Americas. The
Alpha-SiB line, with 55-, 110-, 140-, 165- and 240-ton models, is based on the
popular Fanuc Roboshot Alpha-SiA series. Various injection capacities are
available for highprecision molding applications. Milacron said that it will
deliver its first Alpha S140iB to a custom molder in the Midwest in the second
quarter of 2021.
Milacron and Fanuc adapted the Roboshot Alpha to
meet the requirements of a variety of applications on both the clamping and
injection unit, said the companies. Special features have been developed for
applications involving medical products, liquid silicone rubber, optics,
electrical connectors, and packaging.
The Roboshot Alpha systems have proven especially
popular in the medical and packaging spaces over the last two years, according
to Kent Royer, Technical Product Manager–Roboshot. “Since NPE 2018, we also have
seen a high demand for the integration of Mold-Masters hot runner controllers,”
he added in a prepared statement. “Using Modbus and SPI communications, we’ve
developed capabilities that will reduce human error in operation and allow for
the creation of custom shut-down sequences.”
The Alpha-SiB series includes a
high-resolution/performance Panel iH control and new electrical standards.
Additionally, Milacron has announced that several previous options are now
standard with the iB series, including increased mold stack height, three-stage
air eject, expanded I/O for automation /sequencing, precision clamp-force
control for consistent venting and reduced mold wear, and 200 Operator ID with
custom lockout capability for security control and tracking.
https://www.plasticstoday.com
*******************************************************
PLI Scheme Incentive Rate For
Medical Sector Should Be Revised To 10%: Transasia
Synopsis
"The PLI scheme is an excellent initiative to make
India Atmanirbhar (self-reliant) in the sector. But the incentive rate is just
five per cent for the medical technology companies, while the same for the
automobile industry is 10 per cent. "We urge the government to raise it to 10
per cent," Transasia Bio-Medicals chairman and managing director Suresh Vazirani
told.
The Centre should increase the rate of incentive
under the PLI scheme to 10 per cent from 5 per cent to reduce dependence on
import of medical equipment and boost domestic manufacturing of such products,
an official of a company involving in the sector said on Sunday.
The government has introduced the production-linked
incentive (PLI) scheme to enhance the country's manufacturing capabilities of
medical equipment and encourage the
development of technology.
"The PLI scheme is an excellent initiative to make
India Atmanirbhar (self-reliant) in the sector. But the incentive rate is just
five per cent for the medical technology companies, while the same for the
automobile industry is 10 per cent.
"We urge the government to raise it to 10 per
cent," Transasia Bio-Medicals chairman and managing director Suresh Vazirani
told PTI.
The five per cent incentive rate is "inadequate"
and should be increased to facilitate Indian companies to produce medical
devices not only for the country but also for the overseas markets. According to
an estimate, the import of medical equipment from China accounts for around 25
per cent of the USD 50 billion industry in India.
Indian companies in the medical technology sector
are not able to compete in the global market due to several infrastructural
inefficiencies and high cost of funds, he said. The Rs 1,300 crore company is
planning to set up its fourth manufacturing plant in the country.
The medical-technology firm has three domestic
units and two overseas facilities.
"We are planning to build our fourth domestic
plant. The company is in talks with Telangana and Andhra Pradesh for the
project. It will involve a capital expenditure of Rs 100- 150 crore, and the
facility will produce blood analysers," the official said.
https://economictimes.indiatimes.com
|
